Skip to main content
. 2023 Aug 8;2023(8):CD010872. doi: 10.1002/14651858.CD010872.pub2

Figueras 2007.

Study characteristics
Methods Study design: randomised trial
Follow‐up: 6‐months after surgery
Participants Setting: single‐centre study in Spain
Number randomised: 300 participants
Interventions Intervention: fibrin glue (n = 150)
  • 5 mL of Tissucol (Baxter‐Inmuno, Vienna, Austria) was applied in aerosol form on the raw surface of the liver. An absorbable collagen sponge (Johnson & Johnson) was also applied with manual pressure, after spraying the fibrin glue.


Control: no intervention (n = 150)
  • Neither the fibrin sealant nor the collagen sponge was used.

Outcomes Primary outcomes
  • Mean total blood loss

  • Percentage of participants with intra‐ or postoperative transfusion

  • Mean number packed red cells transfused

  • Percentage with intraoperative fresh frozen plasma transfusion

  • Percentage with intraoperative platelet transfusion


Secondary outcomes
  • Mean number of days postoperative drainage

  • Mean overall drain volume

  • Percentage of reoperations

  • Percentage of biliary fistula, abdominal abscess or abdominal bleeding

  • Percentage requiring percutaneous drainage of collection

  • Mortality

Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation process not specified.
Allocation concealment (selection bias) Unclear risk Method of concealment, if used, not specified.
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Blinding of participants and personnel not specified.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding of participants and personnel not specified.
Incomplete outcome data (attrition bias)
All outcomes Low risk Randomised patients analysed. No dropouts/exclusions after randomisation reported.
Selective reporting (reporting bias) Unclear risk No protocol published.
Other bias Low risk Funding from academic source, with no commercial interest. No other bias identified.